诺和诺德(NVO)盘前跌超25% 新减肥药CagriSema实验效果不及预期

金吾财讯
20 Dec 2024

金吾财讯 | 诺和诺德(NVO)盘前跌超25%,截至发稿,报83.61美元。消息面上,诺和诺德此前公布了新减肥药CagriSema的实验数据:Cagrisema表现出卓越的减肥效果,服用Cagrisema的患者在试验中体重减轻了22.7%,不及此前预期。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10